Sagespring Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Buy
36,327
+4,410
+14% +$422K 0.06% 154
2025
Q4
$3.07M Buy
31,917
+2,531
+9% +$246K 0.06% 151
2025
Q3
$2.8M Buy
29,386
+5,008
+21% +$460K 0.05% 150
2025
Q2
$2.13M Buy
24,378
+1,900
+8% +$161K 0.05% 167
2025
Q1
$2.02M Buy
22,478
+4,794
+27% +$429K 0.05% 155
2024
Q4
$1.41M Buy
+17,684
New +$1.53M 0.04% 175

Other funds holding MDT

Sagespring Wealth Partners's MDT Position: Q1 2026 in Review

Sagespring Wealth Partners increased its Medtronic (MDT) stake by 14% in Q1 2026, buying an estimated $422K and bringing the position to 36,327 shares worth $3.15M. The position accounts for 0.06% of the portfolio, ranked #154.

Sagespring Wealth Partners first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Sagespring Wealth Partners held 36,327 shares of Medtronic worth $3.15M as of Q1 2026.
  • Sagespring Wealth Partners bought 4,410 Medtronic shares in Q1 2026, an estimated $422K.
  • Medtronic made up 0.06% of Sagespring Wealth Partners's portfolio in Q1 2026, its #154 holding.
  • Sagespring Wealth Partners first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.